You can buy or sell PBH and other stocks, options, ETFs, and crypto commission-free!
Prestige Consumer Healthcare, Inc. engages in the marketing, sale, and distribution of pharmaceutical drugs and consumer products. It operates through the following segments: North American OTC Healthcare, and International OTC Healthcare. Read More The North American and International OTC Healthcare segments manages the following brands: BC/Goody's, Beano, Boudreaux's Butt Paste, Chloraseptic, Clear Eyes, Compound W, Debrox, DenTek, Dramamine, Efferdent, Fess, Fleet, Gaviscon, Hydralyte, Luden's, Monistat, Nix, Pedia-Lax, and Summer's Eve. The company was founded in 1996 and is headquartered in Tarrytown, NY.
Tarrytown, New York
52 Week High
52 Week Low
Advertising and Marketing
Yahoo FinanceMay 13
Prestige Consumer Healthcare Inc Files 10-K for the Fiscal Year Ended on March 31, 2019
- By insider Prestige Consumer Healthcare Inc (PBH) files its latest 10-K with SEC for the fiscal year ended on March 31, 2019. Prestige Brands Holdings Inc is a healthcare company. Its core business involves the distribution of healthcare and household cleaning products to supermarkets and drug stores. Prestige Consumer Healthcare Inc has a market cap of $1.56 billion; its shares were traded at around $30.19 with a P/E ratio of 24.74 and P/S ratio of 1.61. Prestige Consumer Healthcare Inc had annual a...
Yahoo FinanceMay 10
Prestige Consumer Q4 Earnings & Sales Beat Estimates
Prestige Consumer Healthcare, Inc. PBH came out with fourth-quarter fiscal 2019 results, wherein both top and bottom lines surpassed the Zacks Consensus Estimate. Shares of the company gained 2.7% on the better-than-expected results. While the bottom line grew year over year, sales declined for the fourth straight quarter. Dismal sales trend has caused this Zacks Rank #4 (Sell) stock to fall 14% in a year’s time, underperforming the industry’s decline of 10.9%. Q4 Details The company posted adj...
Expected Aug 1, Pre-Market